A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid Tumors
Clinical trial NCT03330106 · COMPLETED
Trial details
- NCT number
- NCT03330106
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2019-01-07
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.